RBC cuts Legend Biotech price target to $56
RBC Capital cut its price target on Legend Biotech to $56.00 from $58.00, according to a Benzinga ratings summary.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
RBC cuts Legend Biotech price target to $56
RBC Capital lowered its Legend Biotech price target to $56.00 from $58.00, per ratings actions cited by Benzinga.